Cidara Therapeutics, Inc. (CDTX)
Total Valuation
CDTX has a market cap or net worth of $84.20 million. The enterprise value is $39.89 million.
Market Cap | 84.20M |
Enterprise Value | 39.89M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CDTX has 90.62 million shares outstanding. The number of shares has increased by 1.91% in one year.
Shares Outstanding | 90.62M |
Shares Change (YoY) | +1.91% |
Shares Change (QoQ) | +0.19% |
Owned by Insiders (%) | 7.53% |
Owned by Institutions (%) | 30.91% |
Float | 76.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 5.75 |
PS Ratio | 1.49 |
Forward PS | 2.31 |
PB Ratio | 10.48 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.71 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.54.
Current Ratio | 1.62 |
Quick Ratio | 1.45 |
Debt / Equity | 0.54 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 30.54 |
Financial Efficiency
Return on equity (ROE) is -264.80% and return on invested capital (ROIC) is -255.55%.
Return on Equity (ROE) | -264.80% |
Return on Assets (ROA) | -48.10% |
Return on Capital (ROIC) | -255.55% |
Revenue Per Employee | $774,534 |
Profits Per Employee | -$429,781 |
Employee Count | 73 |
Asset Turnover | 0.87 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CDTX has paid $651,000 in taxes.
Income Tax | 651,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.69% in the last 52 weeks. The beta is 0.94, so CDTX's price volatility has been similar to the market average.
Beta (1Y) | 0.94 |
52-Week Price Change | -22.69% |
50-Day Moving Average | 0.71 |
200-Day Moving Average | 0.85 |
Relative Strength Index (RSI) | 73.07 |
Average Volume (30 Days) | 525,508 |
Short Selling Information
The latest short interest is 179,466, so 0.20% of the outstanding shares have been sold short.
Short Interest | 179,466 |
Short Previous Month | 221,355 |
Short % of Shares Out | 0.20% |
Short % of Float | 0.23% |
Short Ratio (days to cover) | 0.41 |
Income Statement
In the last 12 months, CDTX had revenue of $56.54 million and -$31.37 million in losses. Loss per share was -$0.39.
Revenue | 56.54M |
Gross Profit | 56.15M |
Operating Income | -31.68M |
Pretax Income | -30.05M |
Net Income | -31.37M |
EBITDA | -30.03M |
EBIT | -31.06M |
Loss Per Share | -$0.39 |
Balance Sheet
The company has $48.67 million in cash and $4.36 million in debt, giving a net cash position of $44.31 million or $0.49 per share.
Cash & Cash Equivalents | 48.67M |
Total Debt | 4.36M |
Net Cash | 44.31M |
Net Cash Per Share | $0.49 |
Equity / Book Value | 8.04M |
Book Value Per Share | 0.09 |
Working Capital | 22.08M |
Cash Flow
In the last 12 months, operating cash flow was -$30.71 million and capital expenditures -$336,000, giving a free cash flow of -$31.05 million.
Operating Cash Flow | -30.71M |
Capital Expenditures | -336,000 |
Free Cash Flow | -31.05M |
FCF Per Share | -$0.34 |
Margins
Gross margin is 99.32%, with operating and profit margins of -56.02% and -55.49%.
Gross Margin | 99.32% |
Operating Margin | -56.02% |
Pretax Margin | -53.14% |
Profit Margin | -55.49% |
EBITDA Margin | -53.12% |
EBIT Margin | -54.94% |
FCF Margin | -54.91% |
Dividends & Yields
CDTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.91% |
Shareholder Yield | -1.91% |
Earnings Yield | -37.26% |
FCF Yield | -36.87% |
Analyst Forecast
The average price target for CDTX is $4.67, which is 407.61% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.67 |
Price Target Difference | 407.61% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 12.50% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CDTX has an Altman Z-Score of -8.75 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -8.75 |
Piotroski F-Score | 1 |